The prevalence and incidence of dementia due to Alzheimer's disease: A systematic review and meta-analysis

Canadian Journal of Neurological Sciences

Volumn 43, Issue S1, 2016, Pages S51-S82

  Fiest, Kirsten M ^a,b,c   Roberts, Jodie I ^a,b,c   Maxwell, Colleen J ^a,d,e   Hogan, David B ^a,b,f   Smith, Eric E ^a,b   Frolkis, Alexandra ^a   Cohen, Adrienne ^f   Kirk, Andrew ^g   Pearson, Dawn ^b   Pringsheim, Tamara ^a,b,c   Venegas Torres, Andres ^a   Jetté, Nathalie ^a,b,c  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d UNIVERSITY OF WATERLOO   (Canada)

^e INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^f UNIVERSITY OF CALGARY   (Canada)

^g UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Alzheimer's; Dementia; Meta analysis; Systematic review

Indexed keywords

AGE DISTRIBUTION; ALZHEIMER DISEASE; COMMUNITY; GEOGRAPHIC DISTRIBUTION; HUMAN; INCIDENCE; PREVALENCE; PRIORITY JOURNAL; RESEARCH DIAGNOSTIC CRITERIA; REVIEW; SYSTEMATIC REVIEW; BIBLIOGRAPHIC DATABASE; COMPLICATION; DEMENTIA; DEMOGRAPHY; META ANALYSIS; STATISTICS AND NUMERICAL DATA;

ALZHEIMER DISEASE; DATABASES, BIBLIOGRAPHIC; DEMENTIA; HUMANS; INCIDENCE; PREVALENCE; RESIDENCE CHARACTERISTICS;

EID: 84975515095     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/cjn.2016.36     Document Type: Review

References (167)

1. Demakis GJ. Disability in Alzheimer's disease: causes, consequences, and economic considerations. J Health Hum Serv Adm. 2007;30:292-305.
2. Gillespie P, O'Shea E, Cullinan J, Lacey L, Gallagher D, Ni Mhaolain A, et al. The effects of dependence and function on costs of care for Alzheimer's disease and mild cognitive impairment in Ireland. Int J Geriatr Psychiatry. 2013;28:256-64.
3. World Health Organization. The 10 Leading Causes of Death by Broad Income Group. Geneva: World Health Organization; 2008.
4. Brookmeyer R, Evans DA, Hebert L, Langa KM, Heeringa SG, Plassman BL, et al. National estimates of the prevalence of Alzheimer's disease in the United States. Alzheimers Dement. 2011;7:61-73.
5. Alzheimer A. Über einen eigenartigen schweren Erkrankungsprozeβ der Hirnrincle. Neurol Zentral. 1906;25:1134.
6. Doody RS, Stevens JC, Beck C, Dubinsky RM, Kaye JA, Gwyther L, et al. Practice parameter: management of dementia (an evidencebased review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001;56: 1154-1166.
7. Morris JC. Dementia update 2005. Alzheimer Dis Assoc Disord. 2005;19:100-17.
8. World Health Organization. Dementia: A Public Health Priority. Geneva: World Health Organization; 2012.
9. Alzheimer's Disease International. World Alzheimer Report 2015: The Global Impact of Dementia. An Analysis of Prevalence, Incidence, Cost and Trends. London: Alzheimer's Disease International; 2015.
10. Ziegler-Graham K, Brookmeyer R, Johnson E, Arrighi HM. Worldwide variation in the doubling time of Alzheimer's disease incidence rates. Alzheimers Dement. 2008;4:316-23.
11. Kukull WA, Higdon R, Bowen JD, McCormick WC, Teri L, Schellenberg GD, et al. Dementia and Alzheimer disease incidence: a prospective cohort study. Arch Neurol. 2002;59:1737-46.
12. Jorm AF, Jolley D. The incidence of dementia: a meta-analysis. Neurology. 1998;51:728-33.
13. Jorm AF, Korten AE, Henderson AS. The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr Scand. 1987;76:465-79.
14. Rockwood K, Stadnyk K. The prevalence of dementia in the elderly: a review. Can J Psychiatry. 1994;39:253-7.
15. Fratiglioni L, De Ronchi D, Aguero-Torres H. Worldwide prevalence and incidence of dementia. Drugs Aging. 1999;15: 365-375.
16. Clarfield AM. The decreasing prevalence of reversible dementias: an updated meta-analysis. Arch Intern Med. 2003;163:2219-29.
17. Suh GH, Shah A. A review of the epidemiological transition in dementia: cross-national comparisons of the indices related to Alzheimer's disease and vascular dementia. Acta Psychiatr Scand. 2001;104:4-11.
18. Caesar-Chavannes C, MacDonald S. Cross-Canada Forum: National Population Health Study of Neurological Conditions in Canada. Chronic Dis Inj Can. 2013;33:188-91.
19. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7): e1000097.
20. EndNote X5. . New York: Thompson Reuters, 2011. Available from http://endnote.com/downloads/available-updates.
21. Loney PL, Chambers LW, Bennett KJ, Roberts JG, Stratford PW. Critical appraisal of the health research literature: prevalence or incidence of a health problem. Chronic Dis Inj Can. 1998;19:170-6.
22. Boyle MH. Guidelines for evaluating prevalence studies. Evid Based Ment Health. 1998;1:37-9.
23. Begg C, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088-101.
24. Egger M, Smith G. Bias in meta-analysis detected by simple, graphical test. Br Med J. 1997;315:629-34.
25. R: A Language and Environment for Statistical Computing [computer program]. Vienna, Austria: R Foundation for Statistical Computing; 2011.
26. Schwarzer G. meta: Meta-Analysis with R. R package version 16-1; 2010.
27. Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw. 2010;36:1-48.
28. Canadian study of health and aging: study methods and prevalence of dementia. CMAJ. 1994;150:899-913.
29. Anttila T, Helkala EL, Viitanen M, Kareholt I, Fratiglioni L, Winblad B, et al. Alcohol drinking in middle age and subsequent risk of mild cognitive impairment and dementia in old age: a prospective population based study. BMJ. 2004;329:539.
30. Benedetti MD, Salviati A, Filipponi S, Manfredi M, De Togni L, Gomez Lira M, et al. Prevalence of dementia and apolipoprotein E genotype distribution in the elderly of Buttapietra, Verona Province, Italy. Neuroepidemiology. 2002;21:74-80.
31. Bermejo-Pareja F, Benito-Leon J, Vega S, Olazaran J, de Toledo M, Diaz-Guzman J, et al. Consistency of clinical diagnosis of dementia in NEDICES: A population-based longitudinal study in Spain. J Geriatr Psychiatry Neurol. 2009;22:246-55.
32. Borroni B, Alberici A, Grassi M, Rozzini L, Turla M, Zanetti O, et al. Prevalence and demographic features of early-onset neurodegenerative dementia in Brescia County, Italy. Alzheimer Dis Assoc Disord. 2011;25:341-4.
33. Bottino CMC, Azevedo D Jr, Tatsch M, Hototian SR, Moscoso MA, Folquitto J, et al. Estimate of dementia prevalence in a community sample from São Paulo, Brazil. Dement Geriatr Cogn Disord. 2008;26:291-9.
34. Bowirrat A, Treves TA, Friedland RP, Korczyn AD. Prevalence of Alzheimer's type dementia in an elderly Arab population. Eur J Neurol. 2001;8:119-23.
35. Camicioli R, Willert P, Lear J, Grossmann S, Kaye J, Butterfield P. Dementia in rural primary care practices in Lake County, Oregon. J Geriatr Psychiatry Neurol. 2000;13:87-92.
36. Chen TF, Chiu MJ, Tang LY, Chiu YH, Chang SF, Su CL, et al. Institution type-dependent high prevalence of dementia in longterm care units. Neuroepidemiology. 2007;28:142-9.
37. Dahl A, Berg S, Nilsson SE. Identification of dementia in epidemiological research: a study on the usefulness of various data sources. Aging Clin Exp Res. 2007;19:381-9.
38. de Jesus Llibre J, Fernandez Y, Marcheco B, Contreras N, Lopez AM, Otero M, et al. Prevalence of dementia and Alzheimer's disease in a Havana municipality: a community-based study among elderly residents. MEDICC Rev. 2009;11:29-35.
39. de Silva HA, Gunatilake SB, Smith AD. Prevalence of dementia in a semi-urban population in Sri Lanka: report from a regional survey. Int J Geriatr Psychiatry. 2003;18:711-5.
40. Fish M, Bayer AJ, Gallacher JEJ, Bell T, Pickering J, Pedro S, et al. Prevalence and pattern of cognitive impairment in a community cohort of men in South Wales: methodology and findings from the Caerphilly Prospective Study. Neuroepidemiology. 2008;30:25-33.
41. Fujishima M, Kiyohara Y. Incidence and risk factors of dementia in a defined elderly Japanese population: the Hisayama study. Ann N Y Acad Sci. 2002;977:1-8.
42. Gurvit H, Emre M, Tinaz S, Bilgic B, Hanagasi H, Sahin H, et al. The prevalence of dementia in an urban Turkish population. Am J Alzheimers Dis Other Demen. 2008;23:67-76.
43. Hall KS, Gao S, Baiyewu O, Lane KA, Gureke O, Shen J, et al. Prevalence rates for dementia and Alzheimer's disease in African Americans: 1992 versus 2001. Alzheimer's Dement. 2009;5: 227-233.
44. Harvey RJ, Skelton-Robinson M, Rossor MN. The prevalence and causes of dementia in people under the age of 65 years. J Neurol Neurosurg Psychiatry. 2003;74:1206-9.
45. Herrera E Jr, Caramelli P, Silveira ASB, Nitrini R. Epidemiologic survey of dementia in a community-dwelling Brazilian population. Alzheimer Dis Assoc Disord. 2002;16:103-8.
46. IkedaM, Hokoishi K, Maki N, Nebu A, Tachibana N, Komori K, et al. Increased prevalence of vascular dementia in Japan: a communitybased epidemiological study. Neurology. 2001;57:839-44.
47. Ikejima C, Yasuno F, Mizukami K, Sasaki M, Tanimukai S, Asada T. Prevalence and causes of early-onset dementia in Japan: a population-based study. Stroke. 2009;40:2709-14.
48. Kivipelto M, Helkala EL, Laakso M, Hanninen T, Hallikainen M, Alhainen K, et al. Apolipoprotein E e4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease. Ann Intern Med. 2002;137:149-55.
49. Kivipelto M, Helkala EL, Laakso M, Hanninen T, Hallikainen M, Alhainen K, et al. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ. 2001;322:1447-51.
50. Mathuranath PS, Cherian PJ, Mathew R, Kumar S, George A, Alexander A, et al. Dementia in Kerala, South India: prevalence and influence of age, education and gender. Int J Geriatr Psychiatry. 2010;25:290-7.
51. Meguro K, Ishii H, Yamaguchi S, Ishizaki J, Shimada M, Sato M, et al. Prevalence of dementia and dementing diseases in Japan: the Tajiri Project. Arch Neurol. 2002;59:1109-14.
52. Nunes B, Silva RD, Cruz VT, Roriz JM, Pais J, Silva MC. Prevalence and pattern of cognitive impairment in rural and urban populations from Northern Portugal. BMC Neurol. 2010;10:42.
53. Plassman BL, Langa KM, Fisher GG, Fisher GG, Heeringa SG, Weir DR, et al. Prevalence of dementia in the United States: the aging, demographics, and memory study. Neuroepidemiology. 2007;29:125-32.
54. Polvikoski T, Sulkava R, Myllykangas L, Notkola IL, Niinisto L, Verkkoniemi A, et al. Prevalence of Alzheimer's disease in very elderly people: a prospective neuropathological study. Neurology. 2001;56:1690-6.
55. Rahkonen T, Eloniemi-Sulkava U, Rissanen S, Vatanen A, Viramo P, Sulkava R. Dementia with Lewy bodies according to the consensus criteria in a general population aged 75 years or older. J Neurol Neurosurg Psychiatry. 2003;74:720-4.
56. Rosenblatt A, Samus QM, Steele CD, Baker AS, Harper MG, Brandt J, et al. The Maryland Assisted Living Study: prevalence, recognition, and treatment of dementia and other psychiatric disorders in the assisted-living population of central Maryland. J Am Geriatr Soc. 2004;52:1618-25.
57. Rovio S, Kareholt I, Helkala EL, Viitanen M, Winblad B, Tuomilehto J, et al. Leisure-time physical activity and the risk of dementia and Alzheimer's disease. Lancet Neurol. 2005; 4:705-11.
58. Sahadevan S, Saw SM, Gao W, Tan LC, Chin JJ, Hong CY, et al. Ethnic differences in Singapore's dementia prevalence: the stroke, Parkinson's disease, epilepsy, and dementia in Singapore study. J Am Geriatr Soc. 2008;56:2061-8.
59. Sekita A, Ninomiya T, Tanizaki Y, Doi Y, Hata J, Yonemoto K, et al. Trends in prevalence of Alzheimer's disease and vascular dementia in a Japanese community: the Hisayama Study. Acta Psychiatr Scand. 2010;122:319-25.
60. Shaji S, Bose S, Verghese A. Prevalence of dementia in an urban population in Kerala, India. Br J Psychiatry. 2005;187:90.
61. Spada RS, Stella G, Calabrese S, Bosco P, Anello G, Gueant-Rodriguez RM, et al. Prevalence of dementia in mountainous village of Sicily. J Neurol Sci. 2009;283:62-5.
62. Stevens T, Livingston G, Kitchen G, Manela M, Walker Z, Katona C. Islington study of dementia subtypes in the community. Br J Psychiatry. 2002;180:270-6.
63. Suh GH, Kim JK, Cho MJ. Community study of dementia in the older Korean rural population. Aust N Z J Psychiatry. 2003;37:606-12.
64. Vas CJ, Pinto C, Panikker D, Noronha S, Deshpande N, Kulkarni L, et al. Prevalence of dementia in an urban Indian population. Int Psychogeriatr. 2001;13:439-50.
65. Wada-Isoe K, Uemura Y, Suto Y, Doi K, Imamura K, Hayashi A, et al. Prevalence of dementia in the rural island town of Ama-cho, Japan. Neuroepidemiology. 2009;32:101-6.
66. Wakutani Y, Kusumi M, Wada K, KawashimaM, Ishizaki K, MoriM, et al. Longitudinal changes in the prevalence of dementia in a Japanese rural area. Psychogeriatrics. 2007;7:150-4.
67. Yamada T, Hattori H, Miura A, Tanabe M, Yamori Y. Prevalence of Alzheimer's disease, vascular dementia and dementia with Lewy bodies in a Japanese population. Psychiatry Clin Neurosci. 2001;55:21-5.
68. Zhang ZX, Zahner GEP, Román GC, Liu J, Hong Z, Qu QM, et al. Dementia subtypes in China: prevalence in Beijing, Xian, Shanghai, and Chengdu. Arch Neurol. 2005;62:447-53.
69. Zhou DF, Wu CS, Qi H, Fan JH, Sun XD, Como P, et al. Prevalence of dementia in rural China: impact of age, gender and education. Acta Neurol Scand. 2006;114:273-80.
70. Bowirrat A, Friedland RP, Farrer L, Baldwin C, Korczyn A. Genetic and environmental risk factors for Alzheimer's disease in Israeli Arabs. J Mol Neurosci. 2002;19:239-45.
71. Bowirrat A, Friedland RP, Korczyn AD. Vascular dementia among elderly Arabs in Wadi Ara. J Neurol Sci. 2002;203-4:73-6.
72. Li S, Yan F, Li G, Zhang W, Liu J, Jie X, et al. Is the dementia rate increasing in Beijing? Prevalence and incidence of dementia 10 years later in an urban elderly population. Acta Psychiatr Scand. 2007;115:73-9.
73. Andreasen N, Blennow K, Sjodin C, Winblad B, Svardsudd K. Prevalence and incidence of clinically diagnosed memory impairments in a geographically defined general population in Sweden: The Piteå Dementia Project. Neuroepidemiology. 1999;18:144-55.
74. Arslantas D, Ozbabalik D, Metintas S, Ozkan S, Kalyoncu C, Ozdemir G, et al. Prevalence of dementia and associated risk factors in Middle Anatolia, Turkey. J Clin Neurosci. 2009;16:1455-9.
75. Banerjee TK, Mukherjee CS, Dutt A, Shekhar A, Hazra A. Cognitive dysfunction in an urban Indian population: some observations. Neuroepidemiology. 2008;31:109-14.
76. Borjesson-Hanson A, Edin E, Gislason T, Skoog I. The prevalence of dementia in 95 year olds. Neurology. 2004;63:2436-8.
77. Das SK, Biswas A, Roy J, Bose P, Roy T, Banerjee TK, et al. Prevalence of major neurological disorders among geriatric population in the metropolitan city of Kolkata. J Assoc Physicians India. 2008;56:175-81.
78. Das SK, Biswas A, Roy T, Banerjee TK, Mukherjee CS, Raut DK, et al. A random sample survey for prevalence of major neurological disorders in Kolkata. Indian J Med Res. 2006;124:163-72.
79. Demirovic J, Prineas R, Loewenstein D, Bean J, Duara R, Sevush S, et al. Prevalence of dementia in three ethnic groups: the South Florida program on aging and health. Ann Epidemiol. 2003;13:472-8.
80. Ebly EM, Parhad IM, Hogan DB, Fung TS. Prevalence and types of dementia in the very old: results from the Canadian Study of Health and Aging. Neurology. 1994;44:1593-600.
81. Ganguli M, Chandra V, Kamboh MI, Johnston JM, Dodge HH, Thelma BK, et al. Apolipoprotein E polymorphism and Alzheimer disease: The Indo-US Cross-National Dementia Study. Arch Neurol. 2000;57:824-30.
82. Gascon-Bayarri J, Rene R, Del Barrio JL, De Pedro-Cuesta J, Ramon JM, Manubens JM, et al. Prevalence of dementia subtypes in El Prat de Llobregat, Catalonia, Spain: the PRATICON study. Neuroepidemiology. 2007;28:224-34.
83. Gavrila D, Antunez C, Tormo MJ, Carles R, Garcia Santos JM, Parrilla G, et al. Prevalence of dementia and cognitive impairment in Southeastern Spain: the Ariadna study. Acta Neurol Scand. 2009;120:300-7.
84. Gislason TB, Sjogren M, Larsson L, Skoog I. The prevalence of frontal variant frontotemporal dementia and the frontal lobe syndrome in a population-based sample of 85 year olds. J Neurol Neurosurg Psychiatry. 2003;74:867-71.
85. Guerchet M, M'Belesso P, Mouanga AM, Bandzouzi B, Tabo A, Houinato DS, et al. Prevalence of dementia in elderly living in two cities of Central Africa: the EDAC survey. Dement Geriatr Cogn Disord. 2010;30:261-8.
86. Ikeda M, Fukuhara R, Shigenobu K, Hokoishi K, Maki N, Nebu A, et al. Dementia-associated mental and behavioural disturbances in elderly people in the community: findings from the first Nakayama study. J Neurol Neurosurg Psychiatry. 2004;75:146-8.
87. Jhoo JH, Kim KW, Huh Y, Lee SB, Park JH, Lee JJ, et al. Prevalence of dementia and its subtypes in an elderly urban Korean population: results from the Korean Longitudinal Study on Health and Aging (KLoSHA). Dement Geriatr Cogn Disord. 2008; 26:270-6.
88. Landi F, Russo A, Cesari M, Barillaro C, Onder G, Zamboni V, et al. The ilSIRENTE study: a prospective cohort study on persons aged 80 years and older living in a mountain community of Central Italy. Aging Clin Exp Res. 2005;17:486-93.
89. Lee DY, Lee JH, Ju YS, Lee KU, Kim KW, Jhoo JH, et al. The prevalence of dementia in older people in an urban population of Korea: the Seoul study. J Am Geriatr Soc. 2002;50:1233-9.
90. Li G, Rhew IC, Shofer JB, Rhew IC, Kukull WA, Peskind ER, et al. Age-varying association between blood pressure and risk of dementia in those aged 65 and older: a community-based prospective cohort study. J Am Geriatr Soc. 2007;55:1161-7.
91. Lopez OL, Kuller LH, Fitzpatrick A, Ives D, Becker JT, Beauchamp N. Evaluation of dementia in the cardiovascular health cognition study. Neuroepidemiology. 2003;22:1-12.
92. Lovheim H, Karlsson S, Gustafson Y. The use of central nervous system drugs and analgesics among very old people with and without dementia. Pharmacoepidemiol Drug Saf. 2008; 17:912-8.
93. Magaziner J, German P, Zimmerman SI, Hebel JR, Burton L, Gruber-Baldini AL, et al. The prevalence of dementia in a statewide sample of new nursing home admissions aged 65 and older: diagnosis by expert panel. Epidemiology of Dementia in Nursing Homes Research Group. Gerontologist. 2000;40:663-72.
94. Maneno MK, Lee E, Wutoh AK, Zuckerman IH, Jackson P, Lombardo FA, et al. National patterns of dementia treatment among elderly ambulatory patients. J Natl Med Assoc. 2006;98:430-5.
95. Manton KC, Gu XL, Ukraintseva SV. Declining prevalence of dementia in the U.S. elderly population. Adv Gerontol. 2005;16:30-7.
96. Molero AE, Pino-Ramirez G, Maestre GE. High prevalence of dementia in a Caribbean population. Neuroepidemiology. 2007;29:107-12.
97. Perkins AJ, Hui SL, Ogunniyi A, Gureje O, Baiyewu O, Unverzaqt FW, et al. Risk of mortality for dementia in a developing country: the Yoruba in Nigeria. Int J Geriatr Psychiatry. 2002;17:566-73.
98. Rockwood K, Wentzel C, Hachinski V, Hogan DB, MacKnight C, McDowell I. Prevalence and outcomes of vascular cognitive impairment: Vascular Cognitive Impairment Investigators of the Canadian Study of Health and Aging. Neurology. 2000;54:447-51.
99. ScazufcaM, Menezes PR, Vallada HP, Crepaldi AL, Pastor-ValeroM, Coutinho LM, et al. High prevalence of dementia among older adults from poor socioeconomic backgrounds in São Paulo, Brazil. Int Psychogeriatr. 2008;20:394-405.
100. Vanhanen M, Koivisto K, Moilanen L, Helkala EL, Hanninen T, Soininen H, et al. Association of metabolic syndrome with Alzheimer disease: a population-based study. Neurology. 2006;67:843-7.
101. Wangtongkum S, Sucharitkul P, Silprasert N, Inthrachak R. Prevalence of dementia among population age over 45 years in Chiang Mai, Thailand. J Med Assoc Thai. 2008;91:1685-90.
102. Xu W, Qiu C, Gatz M, Pedersen NL, Johansson B, Fratiglioni L. Mid- and late-life diabetes in relation to the risk of dementia: a population-based twin study. Diabetes. 2009;58:71-7.
103. Zhao Q, Zhou B, Ding D, Guo Q, Hong Z. Prevalence, mortality, and predictive factors on survival of dementia in Shanghai, China. Alzheimer Dis Assoc Disord. 2010;24:151-8.
104. Cornelius C, Fastbom J, Winblad B, Viitanen M. Aspirin, NSAIDs, risk of dementia, and influence of the apolipoprotein E epsilon 4 allele in an elderly population. Neuroepidemiology. 2004;23: 135-143.
105. Evans DA, Bennett DA, Wilson RS, Bienias JL, Morris MC, Scherr PA, et al. Incidence of Alzheimer disease in a biracial urban community: relation to apolipoprotein E allele status. Arch Neurol. 2003;60:185-9.
106. Forti P, Pisacane N, Rietti E, Lucicesare A, Olivelli V, Mariani E, et al. Metabolic syndrome and risk of dementia in older adults. J Am Geriatr Soc. 2010;58:487-92.
107. Ganguli M, Dodge HH, Chen P, Belle S, DeKosky ST. Ten-year incidence of dementia in a rural elderly US community population: the MoVIES Project. Neurology. 2000;54:1109-16.
108. Hendrie HC, Ogunniyi A, Hall KS, Baiyewu O, Unverzagt FW, Gureje O, et al. Incidence of dementia and Alzheimer disease in two communities: Yoruba residing in Ibadan, Nigeria, and African Americans residing in Indianapolis, Indiana. JAMA. 2001;285:739-47.
109. Kawas C, Gray S, Brookmeyer R, Fozard J, Zonderman A. Age-specific incidence rates of Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology. 2000;54:2072-7.
110. Knopman DS, Rocca WA, Cha RH, Edland SD, Kokmen E. Survival study of vascular dementia in Rochester, Minnesota. Arch Neurol. 2003;60:85-90.
111. Kuller LH, Lopez OL, JagustWJ, Becker JT, DeKosky ST, Lyketsos C, et al. Determinants of vascular dementia in the Cardiovascular Health Cognition Study. Neurology. 2005;64:1548-1552.
112. Lopez OL, Kuller LH, Becker JT, Jaqust WJ, DeKosky ST, Fitzpatrick A, et al. Classification of vascular dementia in the Cardiovascular Health Study Cognition Study. Neurology. 2005;64:1539-47.
113. Miech RA, Breitner JCS, Zandi PP, Khachaturian AS, Anthony JC, Mayer L. Incidence of AD may decline in the early 90s for men, later for women: The Cache County Study. Neurology. 2002;58:209-18.
114. Morris MC, Evans DA, Bienias JL, Tangney CC, Bennett DA, Aggarwal N, et al. Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. JAMA. 2002;287:3230-7.
115. Piguet O, Grayson DA, Creasey H, Bennett HP, Brooks WS, Waite LM, et al. Vascular risk factors, cognition and dementia incidence over 6 years in the Sydney Older Persons Study. Neuroepidemiology. 2003;22:165-71.
116. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's Disease. N Engl J Med. 2002;346: 476-483.
117. Zandi PP, Carlson MC, Plassman BL, Welsh-Bohmer KA, Mayer LS, Steffens DC, et al. Hormone replacement therapy and incidence of Alzheimer disease in older women: The Cache County Study. JAMA. 2002;288:2123-9.
118. Bermejo-Pareja F, Benito-León J, Vega S, Medrano MJ, Román GC, Neurological Disorders in Central Spain (NEDICES) Study Group. Incidence and subtypes of dementia in three elderly populations of central Spain. J Neurol Sci. 2008;264:63-72.
119. Chandra V, Pandav R, Dodge HH, Johnston JM, Belle SH, DeKosky ST, et al. Incidence of Alzheimer's disease in a rural community in India: the Indo-US study. Neurology. 2001;57: 985-989.
120. Di Carlo A, Baldereschi M, Amaducci L, Lepore V, Bracco L, Maggi S, et al. Incidence of dementia, Alzheimer's disease, and vascular dementia in Italy: The ILSA Study. J Am Geriatr Soc. 2002;50:41-8.
121. Edland SD, Rocca WA, Petersen RC, Cha RH, Kokmen E. Dementia and Alzheimer disease incidence rates do not vary by sex in Rochester, Minnesota. Arch Neurol. 2002;59:1589-93.
122. Fitzpatrick AL, Kuller LH, Ives DG, Lopez OL, Jagust W, Breitner JC, et al. Incidence and prevalence of dementia in the Cardiovascular Health Study. J Am Geriatr Soc. 2004;52:195-204.
123. Fuhrer R, Dufouil C, Dartigues JF, PAQUID Study. Exploring sex differences in the relationship between depressive symptoms and dementia incidence: prospective results from the PAQUID Study. J Am Geriatr Soc. 2003;51:1055-63.
124. Garre-Olmo J, Genis Batlle D, del Mar Fernandez M, Marquez Daniel F, de Eugenio Huelamo R, Casadevall T, et al. Incidence and subtypes of early-onset dementia in a geographically defined general population. Neurology. 2010;75:1249-55.
125. Knopman DS, Petersen RC, Edland SD, Cha RH, Rocca WA. The incidence of frontotemporal lobar degeneration in Rochester, Minnesota, 1990 through 1994. Neurology. 2004;62:506-8.
126. Kukull WA, Higdon R, Bowen JD, McCormick WC, Teri L, Schellenberg GD, et al. Dementia and Alzheimer disease incidence: a prospective cohort study. Arch Neurol. 2002;59: 1737-46.
127. Larrieu S, Letenneur L, Helmer C, Dartigues JF, Barberger-Gateau P. Nutritional factors and risk of incident dementia in the PAQUID longitudinal cohort. J Nutr Health Aging. 2004;8:150-4.
128. Larrieu S, Letenneur L, Orgogozo JM, Fabrigoule C, Amieva H, Le Carret N, et al. Incidence and outcome of mild cognitive impairment in a population-based prospective cohort. Neurology. 2002;59:1594-9.
129. Lee JY, Chang SM, Jang HS, Chang JS, Suh GH, Jung HY, et al. Illiteracy and the incidence of Alzheimer's disease in the Yonchon County survey, Korea. Int Psychogeriatr. 2008;20:976-85.
130. Lopez-Pousa S, Vilalta-Franch J, Llinas-Regla J, Garre-Olmo J, Román GC. Incidence of dementia in a rural community in Spain: the Girona cohort study. Neuroepidemiology. 2004;23:170-7.
131. Matsui Y, Tanizaki Y, Arima H, Yonemoto K, Doi Y, Ninomiya T, et al. Incidence and survival of dementia in a general population of Japanese elderly: the Hisayama study. J Neurol Neurosurg Psychiatry. 2009;80:366-70.
132. McDowell I, Xi G, Lindsay J, Tierney M. Mapping the connections between education and dementia. J Clin Exp Neuropsychol. 2007;29:127-41.
133. Meguro K, Ishii H, Kasuya M, Akanuma K, Meguro M, Kasai M, et al. Incidence of dementia and associated risk factors in Japan: The Osaki-Tajiri Project. J Neurol Sci. 2007;260:175-82.
134. Mercy L, Hodges JR, Dawson K, Barker RA, Brayne C. Incidence of early-onset dementias in Cambridgeshire, United Kingdom. Neurology. 2008;71:1496-9.
135. Nitrini R, Caramelli P, Herrera E Jr, Bahia VS, Caixeta LF, Radanovic M, et al. Incidence of dementia in a communitydwelling Brazilian population. Alzheimer Dis Assoc Disord. 2004;18:241-6.
136. Perez F, Helmer C, Dartigues JF, Auriacombe S, Tison F. A 15-year population-based cohort study of the incidence of Parkinson's disease and dementia with Lewy bodies in an elderly French cohort. J Neurol Neurosurg Psychiatry. 2010;81:742-6.
137. Phung TKT, Waltoft BL, Kessing LV, Mortensen PB, Waldemar G. Time trend in diagnosing dementia in secondary care. Dement Geriatr Cogn Disord. 2010;29:146-53.
138. Polvikoski T, Sulkava R, Rastas S, Sutela A, Niinisto L, Notkola IL, et al. Incidence of dementia in very elderly individuals: a clinical, neuropathological and molecular genetic study. Neuroepidemiology. 2006;26:76-82.
139. Ravaglia G, Forti P, Lucicesare A, Piscane N, Rietti E, Biachin M, et al. Physical activity and dementia risk in the elderly: findings from a prospective Italian study. Neurology. 2008;70:1786-94.
140. Ravaglia G, Forti P, Maioli F, Martelli M, Servadei L, Brunetti N, et al. Incidence and etiology of dementia in a large elderly Italian population. Neurology. 2005;64:1525-30.
141. Ravaglia G, Forti P, Maioli F, Montesi F, Rietti E, Pisacane N, et al. Risk factors for dementia: data from the Conselice study of brain aging. Arch Gerontol Geriatr. 2007;44(Suppl 1):311-20.
142. Ruitenberg A, Ott A, van Swieten JC, Hofman A, Breteler MM. Incidence of dementia: does gender make a difference? Neurobiol Aging. 2001;22:575-80.
143. Tang MX, Cross P, Andrews H, Jacobs DM, Small S, Bell K, et al. Incidence of AD in African Americans, Caribbean Hispanics, and Caucasians in northern Manhattan. Neurology. 2001;56:49-56.
144. Tyas SL, Tate RB, Wooldrage K, Manfreda J, Strain LA. Estimating the incidence of dementia: the impact of adjusting for subject attrition using health care utilization data. Ann Epidemiol. 2006;16:477-84.
145. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med. 2003;348:1215-22.
146. Waite LM, Broe GA, Grayson DA, Creasey H. The incidence of dementia in an Australian community population: the Sydney Older Persons Study. Int J Geriatr Psychiatry. 2001;16:680-9.
147. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders-IV-Text Revision. Washington, DC: American Psychiatric Association; 1994.
148. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-44.
149. Hendrie HC, Osuntokun BO, Hall KS, Ogunniyi AO, Hui SL, Unverzagt FW, et al. Prevalence of Alzheimer's disease and dementia in two communities: Nigerian Africans and African Americans. Am J Psychiatr. 1995;152:1485-92.
150. Danila O, Hirdes JP, Maxwell CJ, Marrie RA, Patten S, Pringsheim T, Jetté N. Prevalence of neurological conditions across the continuum of care based on interRAI assessments. BMC Health Serv Res. 2014;14:29.
151. Hebert LE, Weuve J, Scherr PA, Evans DA. Alzheimer disease in the United States (2010-2050) estimated using the 2010 census. Neurology. 2013;80:1778-83.
152. Andersen K, Launer LJ, DeweyME, Letenneur L, Ott A, Copeland JR, et al. Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies. EURODEM Incidence Research Group. Neurology. 1999;53:1992-7.
153. Fratiglioni L, Launer LJ, Andersen K, Breteler MM, Copeland JR, Dartiques JF, et al. Incidence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology. 2000;54:S10-5.
154. Mielke MM, Vemuri P, Rocca WA. Clinical epidemiology of Alzheimer disease: assessing sex and gender differences. Clin Epidemiol. 2014;6:37-48.
155. Chene G, Beiser A, Au R, Preis SR, Wolf PA, Dufouil C, et al. Gender and incidence of dementia in the Framingham Heart Study from mid-adult life. Alzheimers Dement. 2015;11:310-20.
156. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. Geneva: World Health Organization; 1993.
157. Erkinjuntti T, Ostbye T, Steenhuis R, Hachinski V. The effect of different diagnostic criteria on the prevalence of dementia. N Engl J Med. 1997;337:1667-74.
158. Wilson RS, Weir DR, Leurgans SE, Evans DA, Hebert LE, Langa KM, et al. Sources of variability in estimates of the prevalence of Alzheimer's disease in the United States. Alzheimers Dement. 2011;7:74-9.
159. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7:263-9.
160. Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, et al. Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria. Lancet Neurol. 2014;13:614-29.
161. Lopez OL, McDade E, Riverol M, Becker JT. Evolution of the diagnostic criteria for degenerative and cognitive disorders. Curr Opin Neurol. 2011;24:532-41.
162. World Health Organization. Life Expectancy at Birth. Geneva: World Health Organization; 2011.
163. Pringsheim T, Jetté N, Frolkis A, Steeves TD. The prevalence of Parkinson's disease: a systematic review and meta-analysis. Mov Disord. 2014:291583-90.
164. Pringsheim T, Wiltshire K, Day L, Dykeman J, Steeves T, Jetté N. The incidence and prevalence of Huntington's disease: a systematic review and meta-analysis. Mov Disord. 2012;27: 1083-1091.
165. Norton S, Matthews FE, Barnes D, Yaffe K, Brayne C. Potential for primary prevention of Alzheimer's disease: an analysis of population-based data. Lancet Neurol. 2014;13:788-94.
166. Schrijvers E, Verhaaren B, Koudstaal P, Hofman A, Ikram MA, Breteler MM. Is dementia incidence declining? Trends in dementia incidence since 1990 in the Rotterdam Study. Neurology. 2012;78:1456-63.
167. Matthews FE, Arthur A, Barnes LE, Bond J, Jagger C, Robinson L, et al. A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II. Lancet. 2013;382:1405-12.